Patent details

Basic Information

Publication number:

EP3331548

PCT Application Number:

US2016042074

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP168251031

PCT Publication Number:

WO2017011544

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-CD154 ANTIBODY HAVING IMPROVED BINDING, FUNCTIONAL AND SAFETY CHARACTERISTICS AND USE IN HUMAN IMMUNOTHERAPY

French Title of Invention:

ANTICORPS ANTI-CD154 OFFRANT DES CARACTÉRISTIQUES DE LIAISON, FONCTIONNALITÉ ET SÉCURITÉ AMÉLIORÉES ET SON UTILISATION DANS L'IMMUNOTHÉRAPIE HUMAINE

German Title of Invention:

ANTI-CD154-ANTIKÖRPER MIT VERBESSERTER BINDUNG, FUNKTIONS- UND SICHERHEITSMERKMALEN UND VERWENDUNG IN DER MENSCHLICHEN IMMUNTHERAPIE

SPC Number:

Dates

Filing date:

13/07/2016

Grant date:

15/04/2026

EP Publication Date:

13/06/2018

PCT Publication Date:

19/01/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/04/2026

EP B1 Publication Date:

15/04/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

13/07/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/04/2026

 

 

Name:

Immunext, Inc.

Address:

16 Cavendish Court, Lebanon, New Hampshire 03766, United States (US)

Inventor

1

Name:

HEARN, Arron

Address:

United Kingdom (GB)

2

Name:

HOLGATE, Robert, George, Edward

Address:

United Kingdom (GB)

3

Name:

ROTHSTEIN, Jay

Address:

United States (US)

Priority

1

Priority Number:

201562192269 P

Priority Date:

14/07/2015

Priority Country:

United States (US)

2

Priority Number:

201562197966 P

Priority Date:

04/03/2026

Priority Country:

United States (US)

3

Priority Number:

201662277201 P

Priority Date:

11/01/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/16; A61K 39/00; A61K 39/395; A61P 37/06;

Publication

European Patent Bulletin

Issue number:

202616

Publication date:

15/04/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/07/2026

Annual Fee Number:

11

Annual Fee Amount:

148 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages